ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      81.965
      -0.19%
      Bitcoin
      66,493.98
      -0.22%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Serono S A (SRA)

      7. Serono S A (SRA) News

      SRA

      Serono (SRA)

      Serono S A
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:SRA
      DateTimeSourceHeadlineSymbolCompany
      01/17/20113:32AMPR Newswire (US)Merck Serono and Domain Therapeutics Announce an Agreement to Develop Drugs for Parkinson's DiseaseNYSE:SRASerono S A
      01/12/20113:01AMPR Newswire (US)Brighter Futures in MS - Inspiring Short Film Premieres in BrusselsNYSE:SRASerono S A
      12/13/20106:00AMPR Newswire (US)Merck Serono and San Raffaele Scientific Institute to Collaborate on Research in Neurodegenerative DiseasesNYSE:SRASerono S A
      11/26/20102:00AMPR Newswire (US)Merck Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of MuNYSE:SRASerono S A
      11/17/20102:46AMPR Newswire (US)Merck Serono: Enrollment Completed for ORACLE MS Study of Cladribine Tablets in Patients at Risk of Developing MSNYSE:SRASerono S A
      11/15/20102:30AMPR Newswire (US)Merck Serono: Ready-to-Use Formulation of Recombinant Growth Hormone Saizen Recommended for Approval in EuropeNYSE:SRASerono S A
      11/04/20102:00AMPR Newswire (US)Merck Serono Announces Top-Line Results of Long-Term Study of Safinamide as Add-on Treatment to Levodopa in Advanced Parkinson'sNYSE:SRASerono S A
      10/28/201010:33AMPR Newswire (US)Merck Serono Sells Théramex to Teva for EUR 265 MillionNYSE:SRASerono S A
      10/25/20105:19AMPR Newswire (US)Merck Serono: REFLEX Study Results Show Treatment With Rebif(R) Delays Conversion to MS in Patients With First Clinical Signs ofNYSE:SRASerono S A
      10/15/20109:30AMPR Newswire (US)Merck Serono to Introduce RebiDose(TM), the Rebif(R) Single Use Pre-filled Pen for Treatment of Multiple SclerosisNYSE:SRASerono S A
      10/13/20103:00AMPR Newswire (US)Merck Serono: New Presentation of Cyanokit(R) Approved in EuropeNYSE:SRASerono S A
      10/11/20102:00AMPR Newswire (US)Merck Serono Notified EMA of its Intention to Appeal CHMP Opinion on Cladribine Tablets in MSNYSE:SRASerono S A
      10/11/20101:30AMPR Newswire (US)Ablynx and Merck Serono Enter into Second Agreement To Co-Discover and Co-Develop Nanobodies (R)NYSE:SRASerono S A
      08/03/20106:38AMPR Newswire (US)Merck Serono Calls for Entries to Real MS - Your Story, a Global Competition to Raise Awareness of Multiple SclerosisNYSE:SRASerono S A
      07/28/20103:05AMPR Newswire (US)Merck Serono: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MSNYSE:SRASerono S A
      07/12/20102:00AMPR Newswire (US)Merck Serono's Cladribine Tablets for MS Approved in RussiaNYSE:SRASerono S A
      06/29/20102:00AMPR Newswire (US)Merck Serono to Award Grant to Innovative Research Projects in FertilityNYSE:SRASerono S A
      06/10/20101:30AMPR Newswire (US)Merck Serono: Data on Safinamide to Be Presented at the 14th MDS MeetingNYSE:SRASerono S A
      06/08/20102:00AMPR Newswire (US)Merck Serono Resubmits U.S. Application for Cladribine Tablets as a Potential MS TherapyNYSE:SRASerono S A
      05/26/20104:00AMPR Newswire (US)Your Story, Your Voice, Your Achievements, Your Ideas ... This Is About Life, Real Life, Real MSNYSE:SRASerono S A
      05/25/20103:07AMPR Newswire (US)International Thyroid Awareness Week 2010 to Focus on Thyroid Disorders and PregnancyNYSE:SRASerono S A
      03/31/20103:00AMPR Newswire (US)Data from Merck Serono's Multiple Sclerosis Portfolio to be Presented at the 62nd Annual Meeting of the American Academy of NeurNYSE:SRASerono S A
      10/10/20081:00AMPR Newswire (US)Merck Serono Named as a Top Employer by Science MagazineNYSE:SRA
      07/06/20075:01AMPR Newswire (US)Squeeze Out of Merck Serono Shares Successfully CompletedNYSE:SRA
      04/26/20076:56PMPR Newswire (US)HealthShares(TM) Announces Changes to the HealthShares(TM) Dermatology & Wound Care, Emerging Cancer, and Composite IndexesNYSE:SRASerono S A
      04/05/200711:00AMPR Newswire (US)Merck Serono S.A. to Voluntarily Delist and Deregister its Bearer Shares and American Depositary Shares (Evidenced by American DNYSE:SRASerono S A
      03/21/20076:08AMPR Newswire (US)Merck Initiates Squeeze Out Procedure for Shares of Merck Serono S.A.NYSE:SRA
      03/21/20073:15AMPR Newswire (US)Merck Serono Confirms Previously Announced 2006 FiguresNYSE:SRA
      03/01/20071:15AMPR Newswire (US)Merck KGaA Announces Serono Preliminary Figures for 2006NYSE:SRA
      02/28/20074:54AMPR Newswire (US)Merck Serono S.A. Preliminary Q4/FY 06 Results - March 1NYSE:SRASerono S A
       Showing the most relevant articles for your search:NYSE:SRA

      Your Recent History

      UNSW3
      TPIUSDT
      Tonpound Participation Index
      Delayed Upgrade Clock